AI Medical Compendium Journal:
Frontiers in aging neuroscience

Showing 1 to 10 of 17 articles

Alzheimer's disease diagnosis using rhythmic power changes and phase differences: a low-density EEG study.

Frontiers in aging neuroscience
OBJECTIVES: The future emergence of disease-modifying treatments for dementia highlights the urgent need to identify reliable and easily accessible tools for diagnosing Alzheimer's disease (AD). Electroencephalography (EEG) is a non-invasive and cost...

An exploration of distinguishing subjective cognitive decline and mild cognitive impairment based on resting-state prefrontal functional connectivity assessed by functional near-infrared spectroscopy.

Frontiers in aging neuroscience
PURPOSE: Functional near-infrared spectroscopy (fNIRS) has shown feasibility in evaluating cognitive function and brain functional connectivity (FC). Therefore, this fNIRS study aimed to develop a screening method for subjective cognitive decline (SC...

Aspirin modulates inflammatory biomarkers in patients with subcortical silent brain infarcts.

Frontiers in aging neuroscience
INTRODUCTION: This study aimed to identify differences in the levels of inflammation-related biomarkers between patients with subcortical silent brain infarcts (SBIs) and healthy controls. We also evaluated the effect of aspirin on the subcortical SB...

Inclusion of hypocretin-1 improved performance of poor sleep quality prediction for elderly patients with acute ischemic stroke: a prospective cohort study.

Frontiers in aging neuroscience
BACKGROUND: Hypocretin-1 is a vital neurotransmitter in regulating the sleep-wake cycle and provides neuroprotection against cerebral ischemia. We aims to develop a poor sleep quality predictive model for elderly population with acute ischemic stroke...

An EEG-based framework for automated discrimination of conversion to Alzheimer's disease in patients with amnestic mild cognitive impairment: an 18-month longitudinal study.

Frontiers in aging neuroscience
BACKGROUND: As a clinical precursor to Alzheimer's disease (AD), amnestic mild cognitive impairment (aMCI) bears a considerably heightened risk of transitioning to AD compared to cognitively normal elders. Early prediction of whether aMCI will progre...

Association between Alzheimer's disease pathologic products and age and a pathologic product-based diagnostic model for Alzheimer's disease.

Frontiers in aging neuroscience
BACKGROUND: Alzheimer's disease (AD) has a major negative impact on people's quality of life, life, and health. More research is needed to determine the relationship between age and the pathologic products associated with AD. Meanwhile, the construct...

Global brain analysis of minor hallucinations in Parkinson's disease using EEG and MRI data.

Frontiers in aging neuroscience
INTRODUCTION: Visual hallucination is a prevalent psychiatric disorder characterized by the occurrence of false visual perceptions due to misinterpretation in the brain. Individuals with Parkinson's disease often experience both minor and complex vis...

Estimating dementia risk in an African American population using the DCTclock.

Frontiers in aging neuroscience
The prevalence of Alzheimer's disease (AD) and related dementias (ADRD) is increasing. African Americans are twice as likely to develop dementia than other ethnic populations. Traditional cognitive screening solutions lack the sensitivity to independ...

A deep learning model for brain age prediction using minimally preprocessed T1w images as input.

Frontiers in aging neuroscience
INTRODUCTION: In the last few years, several models trying to calculate the biological brain age have been proposed based on structural magnetic resonance imaging scans (T1-weighted MRIs, T1w) using multivariate methods and machine learning. We devel...